Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RTT advanced practice and how it can change the future of radiotherapy.
Duffton A, Harnett N, McNair HA, Bennett E, Clarkson M, Guilherme Couto J, Lawler G, Matthews K, Oliveira C, Rozanec N, Simões R, Tsang Y. Duffton A, et al. Among authors: tsang y. Tech Innov Patient Support Radiat Oncol. 2024 Mar 26;30:100245. doi: 10.1016/j.tipsro.2024.100245. eCollection 2024 Jun. Tech Innov Patient Support Radiat Oncol. 2024. PMID: 38595787 Free PMC article.
Indeed, what's in a name?
Gillan C, Harnett N, Davis CA, Dickie C, Liszewski B, Smoke M, Tsang Y, Velec M. Gillan C, et al. Among authors: tsang y. J Med Imaging Radiat Sci. 2023 Jun;54(2):235-237. doi: 10.1016/j.jmir.2023.02.007. Epub 2023 Mar 6. J Med Imaging Radiat Sci. 2023. PMID: 36890030 No abstract available.
ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation.
Mast ME, Leong A, Korreman SS, Lee G, Probst H, Scherer P, Tsang Y. Mast ME, et al. Among authors: tsang y. Tech Innov Patient Support Radiat Oncol. 2023 Sep 12;28:100219. doi: 10.1016/j.tipsro.2023.100219. eCollection 2023 Dec. Tech Innov Patient Support Radiat Oncol. 2023. PMID: 37745181 Free PMC article. No abstract available.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Marvaso G, Jereczek-Fossa BA, Zaffaroni M, Vincini MG, Corrao G, Andratschke N, Balagamwala EH, Bedke J, Blanck O, Capitanio U, Correa RJM, De Meerleer G, Franzese C, Gaeta A, Gandini S, Garibaldi C, Gerszten PC, Gillessen S, Grubb WR, Guckenberger M, Hannan R, Jhaveri PM, Josipovic M, Kerkmeijer LGW, Lehrer EJ, Lindskog M, Louie AV, Nguyen QN, Ost P, Palma DA, Procopio G, Rossi M, Staehler M, Tree AC, Tsang YM, Van As N, Zaorsky NG, Zilli T, Pasquier D, Siva S. Marvaso G, et al. Among authors: tsang ym. Lancet Oncol. 2024 May;25(5):e193-e204. doi: 10.1016/S1470-2045(24)00023-8. Lancet Oncol. 2024. PMID: 38697165 Review.
630 results